FOFA · XBRL financial data
Family Office of America financial statements, every fiscal year
The same tables from 5 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (FOFA's year ends in late December)
| In thousands of dollars | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|
| Revenue from contracts with customers | — | — | — | 222 |
| Gross profit | — | — | — | 222 |
| Research and development | 76 | 2 | — | — |
| General and administrative | 596 | 153 | 97 | 516 |
| Total operating expenses | 921 | 230 | 97 | 723 |
| Operating income (loss) | (921) | (230) | (97) | (501) |
| Other income (expense) | — | 23 | (4) | 14 |
| Net income (loss) | (921) | (805) | (100) | (493) |
| Earnings per share, basic USD per share | (0.11) | (0.09) | 0.00 | (0.02) |
| Earnings per share, diluted USD per share | (0.11) | (0.09) | 0.00 | (0.02) |
| Weighted average shares, basic thousands of shares | 8,334 | 8,476 | 20,262 | 26,676 |
| Weighted average shares, diluted thousands of shares | 8,334 | 8,476 | 20,262 | 26,676 |
Balance sheet
CSVFiscal years (FOFA's year ends in late December)
| In thousands of dollars | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | 70 | 2 | 14 | 156 |
| Accounts receivable | — | — | — | 75 |
| Inventory | 40 | — | — | — |
| Total current assets | 256 | 2 | 21 | 270 |
| Property and equipment, net | 39 | — | — | — |
| Goodwill | — | — | — | 836 |
| Total assets | 295 | 2 | 21 | 1,543 |
| Accrued liabilities | — | 41 | — | — |
| Total current liabilities | 72 | 525 | 44 | 579 |
| Total liabilities | 72 | 525 | 44 | 879 |
| Accumulated deficit | (3,625) | (4,430) | (4,531) | (5,024) |
| Total stockholders' equity | 224 | (523) | (23) | 665 |
| Total liabilities and equity | 295 | 2 | 21 | 1,543 |
| Common shares outstanding (cover page) thousands of shares | 8,476 | 20,440 | 23,190 | 30,452 |
Cash flows
CSVFiscal years (FOFA's year ends in late December)
| In thousands of dollars | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|
| Net income (loss) | (921) | (805) | (100) | (493) |
| Stock-based compensation | (94) | 46 | — | 137 |
| Net cash from operating activities | (558) | (77) | (89) | (262) |
| Net cash from investing activities | — | — | — | (561) |
| Proceeds from issuing common stock | 100 | — | 100 | 965 |
| Net cash from financing activities | 100 | 9 | 101 | 965 |
| Net change in cash | (458) | (67) | 11 | 142 |
Compare with peers
SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Family Office of America | 637 | 533 | 149* | 30.8M | — | 10-QJun 30, 2026 |
| Odyssey Health | 122 | not reported | (160)* | 110.2M | 0.8 quarters | 10-KJul 31, 2026 |
| Aethlon Medical | 4,934 | not reported | (1,897) | 711,136 | 2.6 quarters | 10-QJun 30, 2026 |
| Autonomix Medical | 3,460 | 0 | (3,544) | 971,043 | 1.0 quarters | 10-QJun 30, 2026 |
| Sonoma Pharmaceuticals | 5,338 | 6,406 | (649) | 4.8M | 8.2 quarters | 10-QJun 30, 2026 |
| Glucotrack | 1,124 | not reported | (3,616)* | 10.6M | 0.3 quarters | 10-QJun 30, 2026 |
| Adm Tronics Unlimited | 223 | not reported | (33) | 67.6M | 6.8 quarters | 10-QJun 30, 2026 |
| Bone Biologics | 6,088 | not reported | (532)* | 3.4M | 9.8 quarters | 10-QSep 30, 2026 |
| NutriBand | 3,422 | 438 | (585)* | 12.2M | — | 10-QJul 31, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.